Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibikase Therapeutics, Inc.

1.98
-0.1100-5.26%
Volume:57.88K
Turnover:117.35K
Market Cap:147.20M
PE:-1.71
High:2.09
Open:2.05
Low:1.98
Close:2.09
Loading ...
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Dec 29, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 04, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 12, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 12, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 03, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 30, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 30, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 16, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 30, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933